Effectiveness of topiramate in eleven patients with Dravet syndrome

No To Hattatsu

Volumn 42, Issue 4, 2010, Pages 273-276

  Takahashi, Hiroka ^a   Takahashi, Yukitoshi ^a,b   Mine, Jun ^a   Mukaida, Souichi ^a   Ikegami, Manko ^a   Ikeda, Hiroko ^a   Ohtani, Hideyuki ^a   Shimomura, Jiro ^a   Kubota, Yuko ^a   Fujiwara, Tateki ^a  

^a SHIZUOKA INSTITUTE OF EPILEPSY AND NEUROLOGICAL DISORDERS   (Japan)

^b GIFU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BROMIDE; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; NITRAZEPAM; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ANHIDROSIS; ARTICLE; DIZZINESS; DRAVET SYNDROME; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; MYOCLONUS EPILEPSY; SOMNOLENCE; TREATMENT OUTCOME;

ADOLESCENT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; EPILEPSIES, MYOCLONIC; FEMALE; FRUCTOSE; HUMANS; INFANT; MALE; YOUNG ADULT;

EID: 77954649572     PISSN: 00290831     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Dravet C. Les epilepsies graves de l'enfant. Vie Med 1978,8:534-8.
2. Fujiwara T, Sugawara T, Mazaki-Miyazaki E, et al. Mutations of sodium channel alpha subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic-clonic seizures. Brain 2003;126:531-46. (Pubitemid 36240855)
3. Dravet C, Bureau M, Oguni H, Fukuyama Y, Cokar O. Severe myoclonic epilepsy in infancy (Dravet syndrome). In:Roger J, Bureau M, Dravet C, Genton P, Tassinari C, Wolf P, eds. Epileptic syndromes in infancy, childhood and adolescence. 4th ed. Montrouge:John Libbey Eurotext, 2005:89-113.
4. Kroll-Seger J, Portilla P, Dulac O, Chiron C. Topiramate in the treatment of highly refractory patients with Dravet syndrome. Neuropediatrics 2006;37:325-9. (Pubitemid 46480526)
5. Coppola G, Capovilla G, Montagnini A, et al. Topiramate as add-on drug in severe myoclonic epilepsy in infancy:an Italian multicenter open trial. Epilepsy Res 2002;49:45-8.
6. Ritter F, Glauser TA, Elterman RD, Wyllie E. Effectiveness, tolerability, and safety of topiramate in children with partial-onset seizures. Topiramate YP Study Group. Epilepsia 2000;41(suppl 1):S82-5.
7. Ceulemans B, Boel M, Claes L, et al. Severe myoclonic epilepsy in infancy:toward an optimal treatment. J Child Neurol 2004;19:516-21. (Pubitemid 39481251)
8. Guerrini R, Dravet C, Genton P, Belmonte A, Kaminska A, Dulac O. Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia 1998;39:508-12.
9. Milaeloff Y, de Saint-Martin A, Mancini J, et al. Topiramate:efficacy and tolerability in children according to epilepsy syndromes. Epilepsy Res 2003;53:225-32.
10. Nieto-Barrera M, Candau R, Nieto-Jimenez M, Correa A, del Portal LR. Topiramate in the treatment of severe myoclonic epilepsy in infancy. Seizure 2000;9:590-4.